PAO Group Teams Up With Puration, Alkame, North American Cannabis Holdings On New CBD Nutraceuticals
The company will create and sell new CBD nutraceuticals together with
Alkame Holdings, Inc. (OTC:ALKM), which will take on the role of co-packer, and
North American Cannabis Holdings, Inc. (OTC:USMJ) whose team will help with distribution services.
PAOG is currently working on a CBD pharmaceutical product called RespRx as therapy for chronic obstructive pulmonary disorder. The product is derived from a patented cannabis extraction method.
CBD Nutraceuticals is expected to generate revenue this year, as the first three products will be launched during the fourth quarter of 2021:
PAOG 2021 CBD Nutraceuticals Sales Plan Preview This Friday To Include ALKM and USMJ Partnership Highlights
News provided by
Share this article
Share this article
SANDUSKY, Ohio, May 6, 2021 /PRNewswire/ PAO Group, Inc. (USOTC: PAOG) today highlighted that the upcoming CBD Nutraceutical Sales Rollout Presentation scheduled for tomorrow, Friday, May 7, 2021, will feature the roles Alkame Holdings, Inc. (USOTC: ALKM) and North American Cannabis Holdings, Inc. (USOTC: USMJ) play in the CBD Nutraceutical Rollout.
Last year, PAOG acquired RespRx from Kali-Extracts, Inc. (OTC Pink: KALY). RespRx is a CBD treatment under development for Chronic Obstructive Pulmonary Disorder (COPD) derived from a patented cannabis extraction method - U.S. Patent No. 9,199,960 entitled METHOD AND APPARATUS FOR PROCESSING HERBACEOUS PLANT MATERIALS INCLUDING THE CANNABIS PLANT .
PAOG 2021 CBD Nutraceuticals Rollout Preview This Friday streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
PAO Group, Inc.: PAOG CBD Nutraceuticals to Hit Market This Year
Sandusky, Ohio (Newsfile Corp. - May 4, 2021) - PAO Group, Inc. (OTC Pink: PAOG) today confirmed plans to present the Company s CBD Nutraceutical Sales Rollout Plan this Friday, May 7, 2021.
Last year, PAOG acquired RespRx from Kali-Extracts, Inc. (OTC Pink: KALY). RespRx is a CBD treatment under development for Chronic Obstructive Pulmonary Disorder (COPD) derived from a patented cannabis extraction method - U.S. Patent No. 9,199,960 entitled, METHOD AND APPARATUS FOR PROCESSING HERBACEOUS PLANT MATERIALS INCLUDING THE CANNABIS PLANT.
PAOG is working with
Veristat, a contract research organization (CRO), dedicated to the clinical advance of therapies and treatments through regulatory approval.
Puration Inc.: PURA and ALKM Confirm Additional CBD Infused Products Slated For Development
Dallas, Texas (Newsfile Corp. - April 30, 2021) - Puration, Inc. (OTC Pink: PURA) and Alkame Holdings, Inc. (OTC Pink: ALKM) today announced finalizing an all-new sugar-free formula for EVERx CBD Sports Water.
PURA and ALKM are long-term partners having started work together on the original EVERx CBD Sports Water. ALKM and PURA are working together on the development of new CBD infused products beyond EVERx and anticipate a new product announcement coming soon.
PURA and ALKM, together with North American Cannabis Holdings, Inc. (OTC Pink: USMJ) plan to soon announce the complete market introduction program for Sugar-Free EVERx CBD Sports Water. The first production run of Sugar-Free EVERx CBD Sports Water is anticipated to start imminently.